Business Overview
Active
2023
3
$15M
Seed
1
4
0.1 years
PhaseV develops a platform for adaptive trial design and closed-loop execution, leveraging an intuitive user interface and flexible software architecture along with cutting-edge algorithms such as reinforcement learning and causal ML to support key clinical decisions at any point during the trial
Employee Count
Employee counts updated on a monthly basis.
Lists
News
Stock Chart
Founders (3)
| Name | Position | Military | Classification | Contact |
|---|---|---|---|---|
hiddenElad Berkman | CTO | Talpiot | AI Expert | |
hiddenRaviv Pryluk | CEO | AI Expert | ||
hiddenDan Goldstaub |
Board and Advisors (1)
| Name | Position | Contact |
|---|---|---|
hiddenZvika Orron | General Partner and Board Member |
Revenues (0)
Funding Rounds (1)
$15M
| Round | Date | Capital Raised | Valuation | Investors |
|---|---|---|---|---|
| October 2023 | hidden$15M | 4 |
M&A Events (0)
Investors (4)
| Investor | Investor Type | Location |
|---|---|---|
| Venture Capital | Israel | |
| Corporate Venture Capital | Italy | |
| Venture Capital | Israel | |
| Venture Capital |
